Paul Kenna

Fundador en Spark Therapeutics Ireland Ltd. .

Consumer Services

Health Technology

Perfil

Paul Kenna is the founder of Spark Therapeutics Ireland Ltd.
He is currently the Director-Ocular Genetics Unit at Trinity College Dublin since 2011.
Additionally, he holds positions as a Member at The Royal College of Physicians and the Irish College of Ophthalmologists.
Dr. Kenna obtained a doctorate degree from Trinity College Dublin.

Cargos activos de Paul Kenna

Empresas	Cargo	Inicio
Spark Therapeutics Ireland Ltd. Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland.	Fundador	-
Trinity College Dublin	Corporate Officer/Principal	-
The Royal College of Physicians	Corporate Officer/Principal	-
Irish College of Ophthalmologists	Corporate Officer/Principal	-

Todos los cargos activos de Paul Kenna

Formación de Paul Kenna.

Trinity College Dublin

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Paul Kenna.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Spark Therapeutics Ireland Ltd. Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland.	Health Technology